hormona glp 1 Agonistas del receptor de péptido similar al glucagón tipo (GLP-1) en el manejo del paciente con diabetes mellitus tipo 2. Una aproximación para el nefrólogo Glucagon-like peptide 1 (GLP-1) -
Description
In general, semaglutide was more effective than other drugs in this category, and this effect looks to be dose-dependent, resulting in better weight loss when higher doses are used compared to lower doses in patients with obesity regardless of their diabetes status

For a 250-pound person, the difference between 14% weight loss and 28% weight loss is the difference between losing 35 pounds and losing 70 pounds

Pros and cons of Fella Health No program is perfect
Faurschou A, Pedersen J, Gyldenlve M, et al
Lancet 2, 13001304, doi: S0140-6736(87)91194-9 (1987)

Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
